2016
DOI: 10.1038/gim.2015.78
|View full text |Cite
|
Sign up to set email alerts
|

Clinical phenotype of the recurrent 1q21.1 copy-number variant

Abstract: Purpose:To characterize the clinical phenotype of the recurrent copy-number variation (CNV) at 1q21.1, we assessed the psychiatric and medical phenotypes of 1q21.1 deletion and duplication carriers ascertained through clinical genetic testing and family member cascade testing, with particular emphasis on dimensional assessment across multiple functional domains. Methods:Nineteen individuals with 1q21.1 deletion, 19 individuals with the duplication, and 23 familial controls (noncarrier siblings and parents) spa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

12
163
1
1

Year Published

2016
2016
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 144 publications
(181 citation statements)
references
References 29 publications
12
163
1
1
Order By: Relevance
“…patients, however, without characterizing a distinct facial gestalt [Christiansen et al, 2004;Brunetti-Pierri et al, 2008;Mefford et al, 2008;Velinov and Dolzhanskaya, 2010;Houeijeh et al, 2011;Rosenfeld et al, 2012;Digilio et al, 2013]. Asymptomatic carriers are found in family studies with this microdeletion [Brunetti-Pierri et al, 2008;Mefford et al, 2008;Bottillo et al, 2013;Bernier et al, 2016]. According to DECIPHER (http://decipher.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…patients, however, without characterizing a distinct facial gestalt [Christiansen et al, 2004;Brunetti-Pierri et al, 2008;Mefford et al, 2008;Velinov and Dolzhanskaya, 2010;Houeijeh et al, 2011;Rosenfeld et al, 2012;Digilio et al, 2013]. Asymptomatic carriers are found in family studies with this microdeletion [Brunetti-Pierri et al, 2008;Mefford et al, 2008;Bottillo et al, 2013;Bernier et al, 2016]. According to DECIPHER (http://decipher.…”
Section: Resultsmentioning
confidence: 99%
“…The 1q21.1 deletions have been associated with a heterogeneous clinical phenotype mainly presenting with intellectual disabilities, seizures, psychosis, language disorder, autism, and microcephaly [Brunetti-Pierri et al, 2008;Stefansson et al, 2008;Basel-Vanagaite et al, 2011;Natera-De Benito et al, 2015;Bernier et al, 2016]. Congenital heart defects and a wide range of minor congenital anomalies such as frontal bossing, deep-set eyes, camptodactyly, postaxial polydactyly, mild interdigital membranes, clavicular pseudoarthrosis, rib anomalies, and syndactyly of toes 2 and 3 have been observed in these ( A , B ).…”
Section: Resultsmentioning
confidence: 99%
“…They are among the most frequently described genomic disorders. The 1p36 deletion is characterized by craniofacial dysmorphism, developmental delay, and mental retardation [33], while in 1q21.1 deletion, the presence of psychiatric or behavior alterations and cardiac abnormalities are remarkable [34, 35]. Some clinical characteristics such as developmental delay, heart defects, seizures, skeletal anomalies, and short stature were described in both syndromes [33-37].…”
Section: Discussionmentioning
confidence: 99%
“…Casey et al identified ASD-specific risk haplotypes at 1q21.1 in three different population cluster and PDZK1 was the only gene including in the genetic region shared by all three haplotypes [29]. Furthermore, Bernier et al recently reported an increased prevalence of macrocephaly and increased ASD symptom severity in patients currying the 1q21 duplication [30].…”
Section: Discussionmentioning
confidence: 98%